Skip to main content
. Author manuscript; available in PMC: 2023 Feb 13.
Published in final edited form as: Immunohorizons. 2022 Jul 22;6(7):476–487. doi: 10.4049/immunohorizons.2200006

TABLE IV.

Endogenous (host-originated) and endobiotic (symbiont-originated) CD1d ligands

Name Representative
Chemical Structure
Category Class Activity Reference
3′-Sulfo-galactosyl ceramide (“sulfatide”) graphic file with name nihms-1868329-t0012.jpg Endogenous ligand β-Anomeric sulfatide Type II NKT agonist (38)
PI graphic file with name nihms-1868329-t0013.jpg Endogenous ligand Glycerophospholipid Agonist for specific NKT cell subset (99)
p-LysoPE graphic file with name nihms-1868329-t0014.jpg Endogenous ligand Lysophospholipid (ether-linked) Agonist for thymic/peripheral NKT cells (100)
iGb3 graphic file with name nihms-1868329-t0015.jpg Endogenous ligand Isogloboside Weak agonist (101)
BfaGC (shown as SB2217) graphic file with name nihms-1868329-t0016.jpg Endobiotic ligand (symbiotic B. fragilis) α-GalCer Immunomodulatory (102)

iGb3, isoglobotrihexosylceramide; PI, phosphatidylinositol.